Mechanical Properties of the Mandible in Postmenopausal Women Under Aledronate Treatment.
Alendronate
Dental implant
Elastic modulus
Nanohardness
Osteoporosis
Journal
Journal of the International Academy of Periodontology
ISSN: 2518-3745
Titre abrégé: J Int Acad Periodontol
Pays: England
ID NLM: 100888553
Informations de publication
Date de publication:
01 10 2020
01 10 2020
Historique:
entrez:
27
9
2020
pubmed:
28
9
2020
medline:
28
10
2020
Statut:
epublish
Résumé
This study evaluated the mechanical properties of mandibular bone tissue retrieved from postmenopausal women under alendronate treatment. Twenty postmenopausal women were divided into two groups: healthy postmenopausal subjects (control group) and osteoporotic subjects treated with alendronate (alendronate group). Mandibular bone samples were retrieved with a trephine bur at the time of dental implant placement and fixed in 4% formalin. Samples were processed for hard tissue histology, and the bone surface was analyzed for nanohardness measurement. Nanohardness and elastic modulus were evaluated by using a Berkovich tip with elastic modulus of 1.016x106 MPa, Poisson coefficient of 0.3, and a load of 100 mN. Each cycle was configured with a load time of 18 seconds (speed of 1 mN/second), the discharge time of 18 seconds, and a rest time of 5 seconds during indentation at a depth of 10 μm. The control group presented the highest values for nanohardness and elastic modulus (p less than 0.05) in relation to the osteoporotic subjects. Within the limitations of the study, it can be concluded that treatment with alendronate negatively influenced the mechanical properties of mandibular bone in postmenopausal women by reducing bone nanohardness and elastic modulus.
Substances chimiques
Alendronate
X1J18R4W8P
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
231-235Informations de copyright
Copyright© by the International Academy of Periodontology.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.